Home | Links | Contact Us | More About Intellectual Property | Bookmark

Search patents:

Home

Weight Loss and Supplements

Method-and-composition-for-treatment-of-diabetes

Isolation and formulations of nutrient-rich carotenoids

OF THE INVENTION A principal object of the present invention is to provide a pharmacologically and ...

Copolymers of flavanoid tannins and acrylic monomers

OF THE PREFERRED EMBODIMENTS By suitable choice of tannins and comonomers, a wide variety of ...

Method of controlling release of antimicrobial agents in chewing gum

OF THE PREFERRED EMBODIMENTS In the context of this invention, chewing gum refers to chewing gum, ...

Fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes

Accordingly, an object of the present invention is to solve the foregoing problems by providing a ...

Herbal drug composition for the prevention and treatment of dementia

OF THE INVENTION This invention is explained in more detail as set forth hereunder: This invention ...

Method of controling zebra mussels with extract of Phytolacca dodecandra

OF THE INVENTION INCLUDING THE BEST MODE OF CARRYING IT OUT Representative Phytolacca include P. ...

Substance P-Saporin (SP-SAP) conjugates and methods of use thereof

OF THE INVENTION This invention provides a conjugate comprising Substance P and Saporin (SP-SAP). I...

Anti-pathogen system and methods of use thereof

The present invention relates to an anti-pathogen system that exhibits high transduction efficiency ...

Multimeric immunotoxins

The invention derives from the finding that treatment of animals undergoing lethal GVHD with a ...

Pharmaceutical compositions based on Diclofenae

1. A method for obtaining an average Tmax of diclofenac in a human patient between 5 and 30 minutes ...

Method and composition for treatment of diabetes

Details

Inventors: Dhaliwal, Kirpal S.;
Assignee:
Primary Examiner: Weddington; Kevin E.
Assistant Examiner:
Attorney, Agent or Firm: Thomas; Charles H.

A medicinal composition is provided for treatment of diabetes in a human subject. The medicinal composition of the invention induces a significant reduction in serum glucose due to the regeneration of pancreatic islet cells. A medicinal composition according to the invention necessarily includes a pharmacologically significant quantity of (-)epicatechin augmented with a comparable amount of gymnemic acid. For best results smaller quantities of cinnamomum tamala, syzygium cumini, trigonella foenum graceum, azardichta indica, ficus racemosa, and tinospora cordifolia are also included in the composition. One to two grams of the medicinal composition of the invention are administered to a diabetic human subject three times a day before meals. The unique combination of components in the medicinal composition leads to a regeneration of the pancreas cells which then start producing insulin on their own. Since the composition restores normal pancreatic function, treatment can be discontinued after between about four and twelve months.

DETAILED DESCRIPTION I claim: 1.
A medicinal composition comprising between about 0.
5 grams and about 2.
0 grams of (-)epicatechin and between about 0.
5 and about 2.
0 grams of gymnemic acid.
2.
A medicinal composition according to claim 1 further comprising between about 0.
5 and about 5.
0 grams of cinnamomum tamala.
3.
A medicinal composition according to claim 1 further comprising between about 0.
5 and 6.
0 grams of syzygium cumini.
4.
A medicinal composition according to claim 1 further comprising between about 0.
5 and about 5.
0 grams trigonella foenum graceum.
5.
A medicinal composition according to claim 1 further comprising between about 0.
5 and about 5.
0 grams azardichta indicia.
6.
A medicinal composition according to claim 1 further comprising between about 0.
5 and about 5.
0 grams of ficus racemosa.
7.
A medicinal composition according to claim 1 further comprising between about 0.
5 and about 5.
0 grams of tinospora cordifolia.
8.
A medicinal composition according to claim 1 further comprising between about 0.
5 and about 6.
0 grams of aegle marelose.
9.
A medicinal composition according to claim 1 further comprising between about 0.
5 and about 6.
0 grams of momardica chirantia.
10.
A medicinal composition comprising between about 0.
5 and about 5.
0 grams of pterocarpus marsupium and between about 0.
5 and about 5.
0 grams gymnema sylvestre.
11.
A medicinal composition according to claim 10 wherein said pterocarpus marsupium is in extract form and is present in an amount of between about 0.
5 and about 3.
0 grams.
12.
A medicinal composition according to claim 11 wherein said gymnema sylvestre is in extract form and is present in an amount of between about 0.
5 and 3.
0 grams.
13.
A medicinal composition according to claim 12 further comprising between about 0.
5 and about 5.
0 grams cinnamomum tamala, between about 0.
5 and about 6.
0 grams syzygium cumini, between about 0.
5 and about 5.
0 grams trigonella foenum graceum, between about 0.
5 and about 5.
0 grams azadirachta indica, between about 0.
5 and 5

Related patents

	Process for preparing fat-soluble vitamin active beadlets OF THE INVENTION The present invention relates to a vitamin-active preparation in the form of a water insoluble beadlet comprising the steps of forming an emulsion ...
	Method for making vitamin enriched cereal OF THE INVENTION The present invention relates to R-T-E cooked cereal dough products fortified with beta carotene that exhibit unexpected vitamin efficacy stability. In ...
	Zeaxanthin-containing compositions produced by flavobacterium multivorum I claim: 1. A feed additive comprising a zeaxanthin-containing composition made by culturing a strain of pigmented Flavobacterium multivorum in a nutrient medium that ...
	Enhanced carotenoid accumulation in storage organs of genetically engineered plants The present invention relates to higher plants transformed to contain a heterologous genomic DNA that encodes a non-higher plant phytoene synthase linked to a plastid ...
	Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain OF THE INVENTION The present invention relates to a process for ameliorating the effects of; i.e., reducing the incidence and/or severity of, tibial dyschondroplasia in ...
	Zeaxanthin formulations for human ingestion This invention discloses zeaxanthin preparations which contain the 3R-3'R stereoisomer of zeaxanthin as a sole detectable isomer, packaged in a form that is intended and ...
	Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion This invention discloses a method of making a preparation of zeaxanthin which contains the 3R-3'R stereoisomer (also referred to as the R--R isomer, for convenience) as ...
	Low phosphorus animal feed containing 1.alpha.-hydroxylated vitamin D compounds and method of preparing OF THE PREFERRED EMBODIMENT As used in the description and in the claims, the term hydroxy-protecting group signifies any group commonly used for the temporary ...
	Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a beta-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants It is a general object of this invention to provide a biotechnological method for production of (3S,3'S) astaxanthin. It is a specific object of the invention to provide ...
	DNA strands useful for the synthesis of xanthophylls and the process for producing the xanthophylls What is claimed is: 1. A method for producing a xanthophyll comprising: (a) introducing a DNA strand into a microorganism capable of synthesizing a .beta.-carotene, ...

0.014
Archive: All patents - Links Copyright (c)2006 Eipa-patents.org - All rights reserved